CARDIOVASCULAR ENDOCRINOLOGY: Growth hormone in CVD prediction—a tall order?

    loading  Checking for direct PDF access through Ovid

Abstract

Endocrine and metabolic pathways are a rich ground in which to examine the prognostic significance of biomarkers of cardiovascular risk. Whereas numerous biomarkers for prediction of cardiovascular disease have emerged in the past decade, far fewer have transitioned into clinical practice. Will growth hormone fulfill its potential?

Related Topics

    loading  Loading Related Articles